SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-014548
Filing Date
2021-11-04
Accepted
2021-11-04 15:14:52
Documents
78
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ymab-20210930x10q.htm   iXBRL 10-Q 2178325
2 EX-31.1 ymab-20210930xex31d1.htm EX-31.1 15576
3 EX-31.2 ymab-20210930xex31d2.htm EX-31.2 15485
4 EX-32.1 ymab-20210930xex32d1.htm EX-32.1 7767
5 EX-32.2 ymab-20210930xex32d2.htm EX-32.2 7724
  Complete submission text file 0001558370-21-014548.txt   7771679

Data Files

Seq Description Document Type Size
6 EX-101.SCH ymab-20210930.xsd EX-101.SCH 54913
7 EX-101.CAL ymab-20210930_cal.xml EX-101.CAL 48090
8 EX-101.DEF ymab-20210930_def.xml EX-101.DEF 220481
9 EX-101.LAB ymab-20210930_lab.xml EX-101.LAB 469555
10 EX-101.PRE ymab-20210930_pre.xml EX-101.PRE 376790
11 EXTRACTED XBRL INSTANCE DOCUMENT ymab-20210930x10q_htm.xml XML 1235115
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38650 | Film No.: 211379575
SIC: 2834 Pharmaceutical Preparations